Cannabidiol: Bridge Between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance

Overview

Journal Antioxidants (Basel)

Date 2023 Feb 25

PMID 36830042

Authors

George Jitca

Bianca E osz

Camil E Vari

Carmen-Maria Rusz

Amelia Tero-Vescan

Amalia Puscas

Affiliations

Soon will be listed here.

Abstract

The literature provides scientific evidence for the beneficial effects of cannabidiol (CBD), and these effects extend beyond epilepsy treatment (e.g., Lennox-Gastaut and Dravet syndromes), notably the influence on oxidative status, neurodegeneration, cellular protection, cognitive function, and physical performance. However, products containing CBD are not allowed to be marketed everywhere in the world, which may ultimately have a negative effect on health as a result of the uncontrolled CBD market. After the isolation of CBD follows the discovery of CB1 and CB2 receptors and the main enzymatic components (diacylglycerol lipase (DAG lipase), monoacyl glycerol lipase (MAGL), fatty acid amino hydrolase (FAAH)). At the same time, the antioxidant potential of CBD is due not only to the molecular structure but also to the fact that this compound increases the expression of the main endogenous antioxidant systems, superoxide dismutase (SOD), and glutathione peroxidase (GPx), through the nuclear complex erythroid 2-related factor (Nrf2)/Keep1. Regarding the role in the control of inflammation, this function is exercised by inhibiting (nuclear factor kappa B) NF-κB, and also the genes that encode the expression of molecules with a pro-inflammatory role (cytokines and metalloproteinases). The other effects of CBD on cognitive function and physical performance should not be excluded. In conclusion, the CBD market needs to be regulated more thoroughly, given the previously listed properties, with the mention that the safety profile is a very good one.

Citing Articles

Enhancing Tetrahydrocannabinol's Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011.

Thapa D, Patil M, Warne L, Carlessi R, Falasca M Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40005963 PMC: 11858241. DOI: 10.3390/ph18020148.

3D Printed Bigel: A Novel Delivery System for Cannabidiol-Rich Hemp Extract.

Gosciniak A, Kocaj F, Stasilowicz-Krzemien A, Szymanski M, Karpinski T, Cielecka-Piontek J Gels. 2024; 10(12).

PMID: 39727528 PMC: 11675765. DOI: 10.3390/gels10120770.

The Modulatory Effects and Therapeutic Potential of Cannabidiol in the Gut.

Brown K, Funk K, Figueroa Barrientos A, Bailey A, Shrader S, Feng W Cells. 2024; 13(19.

PMID: 39404382 PMC: 11475737. DOI: 10.3390/cells13191618.

Cannabidiol and Beta-Caryophyllene Combination Attenuates Diabetic Neuropathy by Inhibiting NLRP3 Inflammasome/NFκB through the AMPK/sirT3/Nrf2 Axis.

Khan I, Kaur S, Rishi A, Boire B, Aare M, Singh M Biomedicines. 2024; 12(7.

PMID: 39062016 PMC: 11274582. DOI: 10.3390/biomedicines12071442.

Comprehensive Insight into Cutaneous Application of Hemp.

Zugic A, Martinovic M, Tadic V, Rajkovic M, Racic G, Nesic I Pharmaceutics. 2024; 16(6).

PMID: 38931870 PMC: 11207338. DOI: 10.3390/pharmaceutics16060748.

References

Gamelin F, Cuvelier G, Mendes A, Aucouturier J, Berthoin S, Di Marzo V . Cannabidiol in sport: Ergogenic or else?. Pharmacol Res. 2020; 156:104764. DOI: 10.1016/j.phrs.2020.104764. View

Demirakca T, Sartorius A, Ende G, Meyer N, Welzel H, Skopp G . Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol. Drug Alcohol Depend. 2010; 114(2-3):242-5. DOI: 10.1016/j.drugalcdep.2010.09.020. View

Blazquez C, Chiarlone A, Bellocchio L, Resel E, Pruunsild P, Garcia-Rincon D . The CB₁ cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway. Cell Death Differ. 2015; 22(10):1618-29. PMC: 4563779. DOI: 10.1038/cdd.2015.11. View

Wang Y, Mukhopadhyay P, Cao Z, Wang H, Feng D, Hasko G . Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury. Sci Rep. 2017; 7(1):12064. PMC: 5608708. DOI: 10.1038/s41598-017-10924-8. View

Castillo P, Younts T, Chavez A, Hashimotodani Y . Endocannabinoid signaling and synaptic function. Neuron. 2012; 76(1):70-81. PMC: 3517813. DOI: 10.1016/j.neuron.2012.09.020. View

Appendino G, Chianese G, Taglialatela-Scafati O . Cannabinoids: occurrence and medicinal chemistry. Curr Med Chem. 2011; 18(7):1085-99. DOI: 10.2174/092986711794940888. View

Micale V, Di Marzo V, Sulcova A, Wotjak C, Drago F . Endocannabinoid system and mood disorders: priming a target for new therapies. Pharmacol Ther. 2012; 138(1):18-37. DOI: 10.1016/j.pharmthera.2012.12.002. View

Brancato A, Castelli V, Lavanco G, Tringali G, Micale V, Kuchar M . Binge-like Alcohol Exposure in Adolescence: Behavioural, Neuroendocrine and Molecular Evidence of Abnormal Neuroplasticity… and Return. Biomedicines. 2021; 9(9). PMC: 8470908. DOI: 10.3390/biomedicines9091161. View

Cravatt B, Demarest K, Patricelli M, Bracey M, Giang D, Martin B . Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A. 2001; 98(16):9371-6. PMC: 55427. DOI: 10.1073/pnas.161191698. View

10.

Mechoulam R, Parker L . The endocannabinoid system and the brain. Annu Rev Psychol. 2012; 64:21-47. DOI: 10.1146/annurev-psych-113011-143739. View

11.

Li L, Xuan Y, Zhu B, Wang X, Tian X, Zhao L . Protective Effects of Cannabidiol on Chemotherapy-Induced Oral Mucositis via the Nrf2/Keap1/ARE Signaling Pathways. Oxid Med Cell Longev. 2022; 2022:4619760. PMC: 9165619. DOI: 10.1155/2022/4619760. View

12.

Zuardi A . History of cannabis as a medicine: a review. Braz J Psychiatry. 2006; 28(2):153-7. DOI: 10.1590/s1516-44462006000200015. View

13.

Ohsumi Y . Historical landmarks of autophagy research. Cell Res. 2013; 24(1):9-23. PMC: 3879711. DOI: 10.1038/cr.2013.169. View

14.

Kohnz R, Nomura D . Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids. Chem Soc Rev. 2014; 43(19):6859-69. PMC: 4159426. DOI: 10.1039/c4cs00047a. View

15.

Olivas-Aguirre M, Torres-Lopez L, Valle-Reyes J, Hernandez-Cruz A, Pottosin I, Dobrovinskaya O . Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia. Cell Death Dis. 2019; 10(10):779. PMC: 6791884. DOI: 10.1038/s41419-019-2024-0. View

16.

Llorente-Berzal A, Terzian A, Di Marzo V, Micale V, Viveros M, Wotjak C . 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons. Psychopharmacology (Berl). 2015; 232(15):2811-25. DOI: 10.1007/s00213-015-3917-y. View

17.

Milligan C, Anderson L, Bowen M, Banister S, McGregor I, Arnold J . A nutraceutical product, extracted from Cannabis sativa, modulates voltage-gated sodium channel function. J Cannabis Res. 2022; 4(1):30. PMC: 9185959. DOI: 10.1186/s42238-022-00136-x. View

18.

Moncada S, Rees D, Schulz R, Palmer R . Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci U S A. 1991; 88(6):2166-70. PMC: 51190. DOI: 10.1073/pnas.88.6.2166. View

19.

Wei B, McGuffey J, Blount B, Wang L . Sensitive Quantification of Cannabinoids in Milk by Alkaline Saponification-Solid Phase Extraction Combined with Isotope Dilution UPLC-MS/MS. ACS Omega. 2017; 1(6):1307-1313. PMC: 5611668. DOI: 10.1021/acsomega.6b00253. View

20.

Franco-Vadillo A, Toledo-Blass M, Rivera-Herrera Z, Guevara-Balcazar G, Orihuela-Rodriguez O, Morales-Carmona J . Cannabidiol-mediated RISK PI3K/AKT and MAPK/ERK pathways decreasing reperfusion myocardial damage. Pharmacol Res Perspect. 2021; 9(4):e00784. PMC: 8236079. DOI: 10.1002/prp2.784. View